AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States.
The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism.
It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment.
The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013.
Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Country | United States |
IPO Date | May 22, 2020 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 1,300 |
CEO | Andrew J. Hykes |
Contact Details
Address: 6001 Oak Canyon Irvine, California United States | |
Website | https://www.inarimedical.com |
Stock Details
Ticker Symbol | NARI |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001531048 |
CUSIP Number | 45332Y109 |
ISIN Number | US45332Y1091 |
Employer ID | 45-2902923 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Andrew J. Hykes | Chief Executive Officer, President & Director |
Hussain Rangwala | Chief Technology Officer |
Kevin Strange | Chief Financial Officer |
Dr. Thomas M. Tu M.D. | Chief Medical Officer |
Eric Khairy | Senior Vice President of Marketing |
Karen Silva | Vice President of Finance & Accounting |
Neil Bhalodkar | Vice President of Investor Relations |
Paul A. Koehn | Senior Vice President of Operations |
Shannon Trevino | General Counsel & Corporate Secretary |
Tara Dunn | Senior Vice President & GM of LimFlow |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 08, 2025 | 4 | Filing |
Jan 07, 2025 | SC14D9C | Filing |
Jan 07, 2025 | SC TO-C | Filing |
Jan 07, 2025 | SC TO-C | Filing |
Jan 06, 2025 | SC14D9C | Filing |
Jan 06, 2025 | 8-K | Current Report |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4 | Filing |